Abstract

ADVANCEMENT AND FUTURE SCOPE OF THREE DIMENSIONAL (3D) BIOPRINTED HEART

Sanjay Kumar Elisetti* and Jayant Singh Goud*

Abstract

The revolutionization of organ transplantation led to the first threedimensional (3D) heart with blood vessels. The size of 3D printed organ was reported to be the size of a cherry, according to Israeli professor Tal Dvir of Tek Aviv University in April-2019. Based on activity data for 104 countries in 2008, which represented roughly 90% of the global population, about 100,800 strong organ transplants are performed each year around the world. With 69 400 kidney transplants being the most recent. It is almost 46 percent from living donors and 20,200 liver transplants. There has been a total of 5400 heart transplants, 3400 lung transplants, and 2400 pancreas transplants. After transplantation of organs, such as the kidney, which rejects 25% of the time and the heart, which rejects 40% of the time. Bioprinting organs and tissue patches from a patient's own cells eliminates the need for organ donors and decreases the chance of rejection. This eliminates the issues of organ rejection and long waiting periods for donors.

Keywords: Three Dimensional (3D), Bioprinting, Stem Cells, Differentiation, Bio-Ink, Heart.